This made us reconsider our initial hypothesis that EphB2 might be a bona fide tumor suppressor, and that it might rather possess a dual context-dependent function, mainly modulated by co-expression of cognate ephrin ligands. The gene discussed is EPHB2; the disease is neoplasm.